SHC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Sotera Health Co (SHC) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has positive long-term growth prospects and strong financial performance, the current technical indicators suggest a bearish trend, and insider selling raises concerns. Additionally, the recent secondary offering and reduced stake by a major holder may put downward pressure on the stock in the short term. It is advisable to wait for a better entry point or clearer bullish signals before investing.
The stock is currently in a bearish trend with the MACD histogram at -0.197 and negatively expanding, indicating downward momentum. The RSI is at 12.478, signaling an oversold condition. The stock is trading below key support levels, with the next support at 14.309, suggesting potential further downside.
Analysts have consistently rated the stock as a Buy or Outperform, with price targets ranging from $23 to $24, indicating confidence in long-term growth.
Hedge funds are increasing their positions, with buying activity up 140.83% last quarter.
Strong financial performance in Q4 2025, with revenue, net income, and EPS showing significant YoY growth.
Insiders are selling, with selling activity up 131.94% last month.
Recent secondary offering of 25 million shares by affiliates could dilute the stock and create short-term selling pressure.
A major shareholder, Ananym Capital Management, reduced its stake, signaling potential concerns.
In Q4 2025, Sotera Health reported revenue growth of 4.56% YoY to $303.44M, net income growth of 182.91% YoY to $34.85M, and EPS growth of 200% YoY to $0.12. Gross margin improved to 53.68%, reflecting strong operational efficiency.
Analysts are bullish on the stock, with recent upgrades and price target increases. Citi raised its target to $23, RBC Capital and Piper Sandler have targets of $24, and William Blair initiated coverage with an Outperform rating. Analysts highlight strong fundamentals, defensible market position, and sustainable growth prospects.
